| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT03231202 |
| P17 | country | Canada | Q16 |
| Norway | Q20 | ||
| United States of America | Q30 | ||
| Sweden | Q34 | ||
| Denmark | Q35 | ||
| Germany | Q183 | ||
| Netherlands | Q55 | ||
| United Kingdom | Q145 | ||
| Australia | Q408 | ||
| P582 | end time | 2019-08-01 | |
| P4135 | maximum age | 80 | |
| P2899 | minimum age | 16 | |
| P1132 | number of participants | 224 | |
| P6153 | research site | Karolinska Institutet | Q219564 |
| University of Nottingham | Q472316 | ||
| Denver Health Medical Center | Q3023367 | ||
| P8005 | research subject recruitment status | unknown | Q76651279 |
| P859 | sponsor | Oslo University Hospital | Q3111191 |
| P580 | start time | 2017-07-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Multi-centre, Prospective, Randomized Controlled Study to Compare Outcomes of Non-operative Management (NOM) With and Without Splenic Arterial Embolization (SAE) in Hemodynamically Stable OIS Grade 4 and 5 Splenic Injuries. |